PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- BELSOMRA
- Generic name / active ingredient
- suvorexant
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Oral
- Record reviewed
- 2026-08-30
Copy from the pack in hand
Source-linked reading points
- Do not read the pack mg as a tablet count. U.S. and Japanese strengths and label instructions differ; age, interactions and market cannot be converted by this site into an individual tablet count, timing or make-up plan.
- Suvorexant can affect next-day alertness, attention and motor coordination. If morning drowsiness, slowed reactions, unsteady gait or a fall occurs, do not drive, operate hazardous equipment, add another sleep medicine or use alcohol to ‘help sleep’; seek timely professional review.
- Sleep-walking, sleep-driving, eating, making calls or other activities while not fully awake are complex-sleep-behaviour warning signs. If this occurs, secure immediate safety and contact the prescriber; injury, altered awareness or another acute danger requires local emergency support.
- Alcohol, opioids, benzodiazepines, other sleep/sedative medicines, some allergy medicines and other CNS depressants can add drowsiness, slowed reactions, breathing or fall risk. Do not combine, rotate or share them merely because they are all used at night.
Reviewed presentation examples — compare every field
- Suvorexant 5 mg per tablet; 30-tablet unit-of-use blister carton (3 cards × 10 tablets)NDC 0006-0005-30
- Suvorexant 10 mg per tablet; 30-tablet unit-of-use blister carton (3 cards × 10 tablets)NDC 0006-0033-30
- Suvorexant 15 mg per tablet; 30-tablet unit-of-use blister carton (3 cards × 10 tablets)NDC 0006-0325-30
- Suvorexant 20 mg per tablet; 30-tablet unit-of-use blister carton (3 cards × 10 tablets)NDC 0006-0335-30
- Suvorexant 10 mg per tablet; Japanese PMDA product identityPMDA 22800AMX00671000
- Suvorexant 15 mg per tablet; Japanese PMDA product identityPMDA 22600AMX01302000
- Suvorexant 20 mg per tablet; Japanese PMDA product identityPMDA 22600AMX01303000